American Journal of Kidney Diseases
Volume 54, Issue 3 , Pages 403-405 , September 2009

Stroke in ESRD: The Other Cardiovascular Disease

  • Stephen L. Seliger, MD, MS

      Affiliations

    • Corresponding Author InformationAddress correspondence to Stephen L. Seliger, MD, MS, Department of Medicine, Division of Nephrology, University of Maryland School of Medicine, 22 S. Greene St, Baltimore, MD N3W143

References 

  1. Levey AS. Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start?. Am J Kidney Dis. 1998;32(suppl 3):S5–S13
  2. Kawamura M, Fijimoto S, Hisanaga S, Yamamoto Y, Eto T. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis. 1998;31:991–996
  3. Seliger SL, Gillen DL, Longstreth WT, Kestenbaum B, Stehman-Breen CO. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int. 2003;64:603–609
  4. Kawagishi T, Nishizawa Y, Konishi T, et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48:820–826
  5. Savage T, Clarke AL, Giles M, Tomson CR, Raine AE. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant. 1998;13:2004–2012
  6. Toyoda K, Fujii K, Fujimi S, et al. Stroke in patients on maintenance hemodialysis: A 22-year single-center study. Am J Kidney Dis. 2005;45:1058–1066
  7. Stefanidis I, Bach R, Mertens PR, et al. Influence of hemodialysis on the mean blood flow velocity in the middle cerebral artery. Clin Nephrol. 2005;64:129–137
  8. Nakatani T, Naganuma T, Uchida J, et al. Silent cerebral infarction in hemodialysis patients. Am J Nephrol. 2003;23:86–90
  9. Sozio SM, Armstrong PA, Coresh J, et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: The CHOICE (Choices for Healthy Outcomes in Caring for ESRD) Study. Am J Kidney Dis. 2009;54:468–477
  10. Lloyd-Jones D, Adams R, Carnethon M, et al. American Heart Association Statistics Committee and Stroke Statistics S Heart disease and stroke statistics—2009 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21–e181
  11. Schneider AT, Kissela B, Woo D, et al. Ischemic stroke subtypes: A population-based study of incidence rates among blacks and whites. Stroke. 2004;35:1552–1556
  12. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology. 2004;62:569–573
  13. Wanner C, Krane V, Marz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238–248
  14. Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial. Lancet. 2004;364:685–696
  15. Pancioli AM, Broderick J, Kothari R, et al. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA. 1998;279:1288–1292
  16. Williams LS, Bruno A, Rouch D, Marriott DJ, Mas DJ. Stroke patients' knowledge of stroke: Influence on time to presentation. Stroke. 1997;28:912–915

PII: S0272-6386(09)00641-6

doi: 10.1053/j.ajkd.2009.04.009

American Journal of Kidney Diseases
Volume 54, Issue 3 , Pages 403-405 , September 2009

Article Tools